Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.355
-0.045 (-3.21%)
At close: Aug 1, 2025, 4:00 PM
1.350
-0.005 (-0.37%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Verve Therapeutics Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $82.08 million as of August 1, 2025. Its market cap has decreased by -55.50% in one year.
Market Cap
82.08M
Enterprise Value
-86.39M
1-Year Change
-55.50%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $82.08M, a decrease of -86.73%. That is a compound annual growth rate of -38.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 81.77M | -20.87% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |